Article
Chest  (2019)

TREATMENT BENEFITS ASSOCIATED WITH OPEN LABEL ORAL TREPROSTINIL AFTER CLINICAL WORSENING IN THE PHASE 3 FREEDOM-EV STUDY FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

White, R.; Grünig, Ekkehard; Jerjes-Sanchez, Carlos; Meyer, Gisela; Pulido, Tomás; SEPULVEDA, PABO; Wang, Kuo; Deng, Chunqin; Grover, Rob; Ousmanou, Aliou; Solum, Derek; Tapson, Victor